Cargando…
Cisplatin-Induced Bradycardia: A Silent Risk Observed in Two Different Clinical Cases
Cisplatin is a platinum-containing drug that inhibits DNA synthesis by inhibiting cross-linking, denaturing DNA strands. It is used in combination with other chemotherapeutic agents to treat several types of cancers. Numerous adverse effects have been reported with this compound. However, it is cons...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686342/ https://www.ncbi.nlm.nih.gov/pubmed/34950548 http://dx.doi.org/10.7759/cureus.19769 |